Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.
Aurore TouzartEtienne LenglinéMehdi LatiriMohamed BelhocineCharlotte SmithXavier ThomasSalvatore SpicugliaDenis PuthierFrançoise PflumioThibaut LeguayCarlos GrauxYves ChalandonFrançoise HuguetStéphane LeprêtreNorbert IfrahHervé DombretElizabeth MacintyreMathilde HunaultNicolas BoisselVahid AsnafiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
We conclude that ASNS methylation status at diagnosis may allow individual adaptation of l-asparaginase dose.